Wolverine Trading’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Wolverine Trading’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,921	Closed	-$18K	–	6559
2018 Q2	$18K	Hold	11,921	–	–	﹤0.01%	5021
2018 Q1	$18K	Buy	+11,921	New	+$20.8K	﹤0.01%	5021
2017 Q3	–	Sell	-20,647	Closed	-$27.6K	–	5586
2017 Q2	$29K	Buy	+20,647	New	+$29.8K	﹤0.01%	4132
2016 Q4	–	Sell	-24,906	Closed	-$120K	–	5784
2016 Q3	$120K	Buy	24,906 +6,548	+36%	+$29.9K	﹤0.01%	4111
2016 Q2	$62K	Buy	+18,358	New	+$69.3K	﹤0.01%	3781

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wolverine Trading's ARLZ Position: Q3 2018 in Review

Wolverine Trading sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 11,921 shares — an estimated $18K sold.

Wolverine Trading first reported a position in ARLZ in Q2 2016 and held it in 5 quarters. The position peaked at $120K in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Wolverine Trading reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Wolverine Trading sold 11,921 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $18K.
Wolverine Trading first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 5 quarters.
Wolverine Trading's Aralez Pharmaceuticals Inc. position peaked at $120K in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Wolverine Trading's 13F filing for Q3 2018, filed 14 Nov 2018.